The quality of care can be improved by the development and implementation of evidence-
based treatment guidelines. Different national guidelines for chronic obstructive pulmonary …

COPD is a significant cause of morbidity and mortality. In some patients with COPD,
eosinophils contribute to inflammation that promotes airway obstruction; approximately a …

Patients with asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS)
have been largely excluded from pivotal therapeutic trials and, as a result, its treatment …

Background Treatment guidelines recommend the use of inhaled long-acting
bronchodilators to alleviate symptoms and reduce the risk of exacerbations in patients with …

Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …

Background The overlap between asthma and COPD is increasingly recognised. This
review examines the new insights, treatment and remaining knowledge gaps for asthma …

The publication of the Spanish guideline for chronic obstructive pulmonary disease–COPD–
(GesEPOC) has brought about a change in the approach to the treatment of this disease …

Computed tomography scan images have been used to identify different radiological COPD
phenotypes based on the presence and severity of emphysema, bronchial wall thickening …

The relevance of the ACOS is to identify patients with COPD who may have underlying
eosinophilic inflammation that responds to inhaled corticosteroids. So far, the previous …

La enfermedad pulmonar obstructiva crónica (EPOC) presenta una gran heterogeneidad
clínica, por lo que su tratamiento se debe individualizar según el nivel de riesgo y el …